A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

227

Participants

Timeline

Start Date

June 10, 2022

Primary Completion Date

September 29, 2023

Study Completion Date

September 29, 2023

Conditions
Plaque Psoriasis
Interventions
DRUG

JNJ-77242113

JNJ-77242113 tablet will be administered orally.

Trial Locations (60)

333

Chang-Gung Memorial Hospital, LinKou Branch, Taoyuan District

704

National Cheng Kung University Hospital, Tainan City

10048

National Taiwan University Hospital, Taipei

10789

ISA - Interdisciplinary Study Association GmbH, Berlin

13620

Seoul National University Bundang Hospital, Gyeonggi-do

13627

CRS Clinical Research Services Berlin GmbH, Berlin

15213

University of Pittsburgh Department of Dermatology, Pittsburgh

15831

Gemeinschaftspraxis Scholz/Sebastian/Schilling, Mahlow

22391

MensingDerma research GmbH, Hamburg

24105

Universitatsklinikum Schleswig Holstein Kiel, Kiel

28041

Hosp. Univ. 12 de Octubre, Madrid

33613

Forcare Clinical Research Inc, Tampa

34470

Renstar Medical Research, Ocala

44793

Niesmann & Othlinghaus GbR, Bochum

46026

Hosp. Univ. I Politecni La Fe, Valencia

46168

Indiana Clinical Trial Center, Plainfield

46940

Hosp. de Manises, Valencia

48059

Hamzavi Dermatology, Fort Gratiot

48455

Fachklinik Bad Bentheim, Bad Bentheim

49241

Pusan National University Hospital, Busan

58453

Hautarztpraxis, Witten

60008

Arlington Dermatology, Rolling Meadows

60590

Universitatsklinikum Frankfurt, Frankfurt am Main

64283

Rosenpark Research GmbH, Darmstadt

69120

Universitaetsklinikum Heidelberg, Heidelberg

72037

Centre Hospitalier Le Mans, Le Mans

75231

Modern Research Associates, Dallas

76031

Hopital Charles Nicolle, Rouen

77004

Center for Clinical Studies, Houston

77598

Center for Clinical Studies, Webster

83342

Chang Gung Memorial Hospital, Kaohsiung City

83800

HIA Sainte Anne, Toulon

86031

Dermodent Centrum Medyczne Aldona Czajkowska Rafal Czajkowski S C, Osielsko

88045

Derma-Study-Center Friedrichshafen GmbH, Friedrichshafen

89119

Vivida Dermatology, Las Vegas

95815

Pacific Skin Institute, Sacramento

97210

Oregon Dermatology and Research Center, Portland

99202

Premier Clinical Research, Spokane

08520

Windsor Dermatology, PC, East Windsor

L8N 1Y2

Dermatrials Research, Hamilton

N2J 1C4

Alliance Clinical Trials, Waterloo

N8T 1E6

XLR8 Medical Research, Windsor

H2H2B5

Innovaderm Research Inc., Montreal

080-0013

Takagi Dermatological Clinic, Obihiro-shi

593 8324

Kume Clinic, Sakai

060-0063

Sapporo Skin Clinic, Sapporo

420-8527

Shizuoka General Hospital, Shizuoka

933-0871

Shirasaki Dermatology Clinic, Takaoka

930 8550

Toyama Prefectural Central Hospital, Toyama

221 0825

Nomura Dermatology Clinic, Yokohama

15-351

Nzoz Zdrowie Osteo-Medic, Bialystok

90-265

Dermed Centrum Medyczne Sp z o o, Lodz

02-953

Klinika Ambroziak Estederm Sp. z o.o, Warsaw

51-685

Wro Medica, Wroclaw

03080

Seoul National University Hospital, Seoul

05030

Konkuk University Medical Center, Seoul

102-1703

KyungHee University Hospital, Seoul

08916

Hosp. Univ. Germans Trias I Pujol, Barcelona

SE1 9RT

Guys and St Thomas NHS Foundation Trust, London

SO16 6YD

University Hospital Southampton NHS Foundation Trust, Southampton

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY